Delivery Order SPE2DR25D3501-SPE2DR26FM2UV
Award Date 1/21/26
Potential Completion Date 1/22/26
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,196.02 to AmerisourceBergen Drug Corp for 4,568,895,450 units of Actemra 400 mg/20 mL vials on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $39,176.41 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $19,657.60 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with a completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $39,386.96 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on November 28, 2025, with an ultimate completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $24,509.54 to Amerisourcebergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on January 16, 2026, with an ultimate completion date of January 20, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, which is also the location of Amerisourcebergen Drug Corp's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,832.40 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on January 20, 2026, with completion expected by January 21, 2026. This award is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through an open solicitation process. The pharmaceutical will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,416.20 to AmerisourceBergen Drug Corp for ACTEMRA 400 mg/20 ml vials on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $6,123.36 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX) valued at $999.99 billion and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Actemra 80 mg/4 mL vials, with a ceiling value of $1,924.58 and an ultimate completion date of December 16, 2025. This non-set-aside, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $7,257.71 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on January 21, 2026, with completion scheduled for January 22, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other...